IDEXX LABORATORIES INC /DE - 8-K Filing

IDEXX Laboratories raises 2026 revenue and EPS guidance following 10% Q3 revenue growth. (Items: 2.02 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject t)

5 articles from 1 source · updated November 5, 2026, 21:21 UTC

Coverage

• Pulsenmore Ltd. - 4 Filing SEC EDGAR · November 5, 2026, 21:15 UTC
• Genpact LTD - 8-K Filing SEC EDGAR · November 5, 2026, 21:11 UTC
• IDEXX LABORATORIES INC /DE - 10-Q Filing SEC EDGAR · November 2, 2026, 21:29 UTC
• SUPERIOR GROUP OF COMPANIES, INC. - 8-K Filing SEC EDGAR · November 2, 2026, 13:01 UTC
• IDEXX LABORATORIES INC /DE - 8-K Filing SEC EDGAR · November 2, 2026, 11:30 UTC